Item 1A. RISK FACTORS
3K characters. Original on sec.gov ·
Item 1A. RISK FACTORS
There have been no material changes with respect to the risk factors disclosed in our 2024 Form 10-K.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The following table contains information with respect to purchases made by or on behalf of Equifax or any “affiliated purchaser” (as defined in Rule 10b-18(a) (3) under the Securities Exchange Act of 1934), of our common stock during the quarter ended September 30, 2025:
| Total Number of Shares | Average Price Paid | Total Number of Shares Purchased as Part of Publicly-Announced | Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or | |||||||||||||||||||||||
| Period | Purchased (1) | Per Share (2) | Plans or Programs | Programs (3) | ||||||||||||||||||||||
| July 1 - July 31, 2025 | 430,132 | $ | 244.50 | 429,484 | $ | 2,767,600,952 | ||||||||||||||||||||
| August 1 - August 31, 2025 | 664,239 | $ | 242.24 | 663,278 | $ | 2,606,928,489 | ||||||||||||||||||||
| September 1 - September 30, 2025 | 144,600 | $ | 237.35 | 144,600 | $ | 2,572,607,679 | ||||||||||||||||||||
| Total | 1,238,971 | 1,237,362 |
(1)The total number of shares purchased for the quarter includes, if applicable: (a) shares purchased pursuant to our publicly-announced share repurchase program (429,484 shares for the month of July 2025, 663,278 shares for the month of August 2025, and 144,600 shares for the month of September 2025); and (b) shares surrendered, or deemed surrendered, in satisfaction of the exercise price and/or to satisfy tax withholding obligations in connection with the exercise of employee stock options and vesting of restricted stock (648 shares for the month of July 2025, 961 shares for the month of August 2025, and 0 shares for the month of September 2025).
(2)Average price paid per share for shares purchased as part of our existing repurchase program (excludes brokerage commissions and excise taxes).
(3)On April 21, 2025, the Board of Directors terminated the existing share repurchase authorization and approved an authorization to repurchase up to $3 billion of shares of common stock. At September 30, 2025, approximately $2.6 billion was available for future purchases of common stock under our share repurchase authorization. The program does not have a stated expiration date.
Dividend and Share Repurchase Restrictions
Our Revolver restricts our ability to pay cash dividends on our capital stock or repurchase capital stock if a default or event of default exists or would result if these payments were to occur, according to the terms of the applicable credit agreements.
Previous: Item 4. CONTROLS AND PROCEDURES · Next: Item 5. OTHER INFORMATION